BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/30/2022 5:08:22 AM | Browse: 387 | Download: 1154
 |
Received |
|
2021-07-30 13:55 |
 |
Peer-Review Started |
|
2021-07-30 13:58 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-10-25 08:38 |
 |
Revised |
|
2021-11-02 10:18 |
 |
Second Decision |
|
2022-03-07 06:06 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-03-16 16:25 |
 |
Articles in Press |
|
2022-03-16 16:25 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2022-02-27 15:04 |
 |
Typeset the Manuscript |
|
2022-04-13 08:24 |
 |
Publish the Manuscript Online |
|
2022-04-30 05:08 |
Category |
Urology & Nephrology |
Manuscript Type |
Case Report |
Article Title |
Primitive neuroectodermal tumor of the prostate in a 58-year-old man: A case report and review of the literature
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Da-Wei Tian, Xiao-Chun Wang, Hui Zhang and Yan Tan |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China (General Program) |
81971593 |
National Natural Science Foundation of China (General Program) |
81771824 |
National Natural Science Foundation of China (General Program) |
81971592 |
National Natural Science Foundation of China (General Program) |
82071893 |
Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province |
20200003 |
|
Corresponding Author |
Yan Tan, MD, Professor, Department of Radiology, First Hospital of Shanxi Medical University, 85 Jiefang South Road, Taiyuan 030001, Shanxi Province, China. tanyan123456@sina.com |
Key Words |
Primitive neuroectodermal tumor; Prostate; Combination therapy; Magnetic resonance imaging; CD99; Case report |
Core Tip |
Prostatic primitive neuroectodermal tumors (PNETs) are usually malignant and occur in young men (median age 29 years; range: 20 to 58 years) with predominant complaints of dysuria, often with normal prostate specific antigen (PSA) levels. Prostatic PNETs may invade adjacent organs, including bladder, rectum, and seminal vesicles, and are prone to distant metastasis. Forty-four percent of patients develop metastases, most commonly (75%) in the lung. CD99 is the most accepted immunohistochemical marker for prostatic PNET. Almost all patients receive chemotherapy. Despite combination therapy, including surgery, chemotherapy, and radiotherapy, the median survival of the patients remains 13 months. |
Publish Date |
2022-04-30 05:08 |
Citation |
Tian DW, Wang XC, Zhang H, Tan Y. Primitive neuroectodermal tumor of the prostate in a 58-year-old man: A case report. World J Clin Cases 2022; 10(13): 4145-4152 |
URL |
https://www.wjgnet.com/2307-8960/full/v10/i13/4145.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v10.i13.4145 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345